|
|
Preventing Cardiovascular Risk
|
|
|
|
Circulatory Disease Mortality Target
|
|
|
|
Evolution of Atherosclerosis
|
|
|
|
Traditional CVD Risk Reduction Strategy
|
|
|
|
LDL Lowering and CV Outcome
|
|
|
|
CV Risk Reduction
|
|
|
|
Coronary Heart Disease Mortality
|
|
|
|
Diabetes in Saudi Arabia
|
|
|
|
Atherosclerosis: ‘Investing in your Arteries’
|
|
|
|
Prevalence of Atherosclerosis by Donor Age
|
|
|
|
CV Risk Factors in Childhood and Carotid IMT in Adults
|
|
|
|
Framingham Heart Study Lifetime Risk
|
|
|
|
Primary Prevention: Influence of Age on Relationship Between Cholesterol and CHD
|
|
|
|
JBS 2 Risk Guidelines 2005
|
|
|
|
Treatment Delay Until “High Risk”
|
|
|
|
Early Modest Treatment: Lifestyle
|
|
|
|
Short Term v. Lifetime Risk in USA
|
|
|
|
|
CV Risk Management
|
|
|
|
Familial Hyper
Cholesterolaemia
|
|
|
|
Age and CV Risk in Diabetes
|
|
|
|
Number of Prescriptions for
|
|
|
|
ALSPAC:
|
|
|
|
Benefit of Smoking Cessation
|
|
|
|
CV Effects of Smoking Ban in Public Places
|
|
|
|
Slide 26
|
|
|
|
Slide 27
|
|
|
|
|
New UK Approach
|
|
Share this page with your colleagues and friends: